Quince Therapeutics Inc.
1.76
0.05 (2.92%)
At close: Jan 15, 2025, 3:59 PM
1.76
0.00%
After-hours Jan 15, 2025, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -31.39M -51.66M -89.94M -76.85M -36.98M -12.48M -12.23M
Depreciation & Amortization 322.00K 204.00K 344.00K 332.00K 188.00K 51.00K 45.00K
Stock-Based Compensation 5.22M 16.62M 29.85M 14.47M 2.06M 155.00K 38.00K
Other Working Capital 2.27M -3.89M -5.62M 9.75M -676.00K -367.00K 237.00K
Other Non-Cash Items 5.82M 913.00K 199.00K 367.00K 367.00K 1.11M 1.64M
Deferred Income Tax -248.00K -284.00K 878.00K 635.00K -812.00K -145.00K 222.00K
Change in Working Capital 1.98M -9.83M -4.26M 10.23M 1.90M -390.00K 460.00K
Operating Cash Flow -18.29M -44.04M -62.93M -50.82M -33.28M -11.70M -9.83M
Capital Expenditures -160.00K -133.00K -180.00K -52.00K -55.00K -212.00K -77.00K
Acquisitions -2.12M 10.59M -58.95M 52.43M -812.00K n/a n/a
Purchase of Investments -113.78M -75.02M -38.79M -187.14M -135.41M -55.24M n/a
Sales Maturities Of Investments 111.21M 82.49M 97.92M 134.76M 117.72M 8.70M n/a
Other Investing Acitivies -910.00K 70.00K 58.95M -52.43M 812.00K -46.54M n/a
Investing Cash Flow -5.76M 18.00M 58.95M -52.43M -17.75M -46.75M -77.00K
Debt Repayment -6.00K -49.00K n/a -34.00K -559.00K 250.00K 7.75M
Common Stock Repurchased 63.73M n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 149.00K 148.00K 6.81M 1.28M 98.00K 75.68M n/a
Financial Cash Flow 143.00K 707.00K 6.81M 118.88M 77.37M 75.93M 7.75M
Net Cash Flow -23.83M -25.14M 2.88M 15.63M 26.34M 17.48M -2.15M
Free Cash Flow -18.45M -44.17M -63.11M -50.87M -33.33M -11.91M -9.90M

Create Price Alert on QNCX

Your price alert will notify you when the stock price is above 1.76.

Add to Watchlist